CA
NZ
UK
AU
IND
US
Strategy Inc filed an 8-K current report on August 17, 2026, disclosing weekly at-the-market offering activity, bitcoin holdings, share repurchase program updates, and the balance of its USD Reserve as of August 16, 2026.
Bakkt, Inc. filed a Form 8-K on August 17, 2026, reporting the departure of Chief Financial Officer Karen Alexander effective August 14, 2026, and the appointment of Matt White as CFO effective August 17, 2026, both disclosed under Item 5.02.
WhiteFiber, Inc. filed a Form 8-K with the SEC on August 17, 2026, disclosing that its wholly owned subsidiary entered into a Real Estate Purchase and Sale Agreement on August 16, 2026, to acquire industrial property in Yadkin County, North Carolina, for a cash …
ScanSource, Inc. filed a Form 8-K with the SEC on August 17, 2026, disclosing the retirement of long-serving board director Peter C. Browning, effective August 12, 2026.
Anavex Life Sciences Corp. filed a Form 8-K with the SEC on August 17, 2026, disclosing under Regulation FD that it had issued a press release and mailed a letter to stockholders in connection with its 2026 Annual Meeting of Stockholders.
Labcorp Holdings Inc. filed a Form 8-K on August 17, 2026, disclosing under Regulation FD that it will host an Investor Day on September 10, 2026, where senior executives will discuss the company's strategy, capital deployment priorities, and long-term financial outlook.
Serve Robotics Inc. filed an 8-K current report on August 17, 2026, disclosing lower than expected delivery volume through its Uber Eats partnership and reduced revenue in the second quarter of 2026, with reduced demand anticipated for the second half of 2026.
HomeTrust Bancshares, Inc. filed a Form 8-K with the SEC on August 17, 2026, disclosing that on August 16, 2026, it entered into an Agreement and Plan of Merger with Blue Ridge Bankshares, Inc. under which Blue Ridge would be acquired by HomeTrust in …
Fulcrum Therapeutics, Inc. filed an 8-K with the SEC on August 17, 2026, disclosing that it entered into an Agreement and Plan of Merger with Slate Medicines, Inc. on August 16, 2026, under which the two Delaware corporations would combine in a transaction structured …
Hanmi Financial Corporation filed a Current Report on Form 8-K with the SEC on August 17, 2026, disclosing that it made available an investor slide presentation covering the company's operating and growth strategies and financial performance.
Please wait processing your request...